NCT02747732 2019-04-23
Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL
Sheba Medical Center
Phase 2 Unknown
Sheba Medical Center
Jichi Medical University
Shandong Lanjin Pharmaceuticals Co.,Ltd